JUNNBRY

Welcome to the Brand page for “JUNNBRY”, which is offered here for Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and autoimmune diseases and disorders; pharmaceutical preparations, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases;.

Its status is currently believed to be active. Its class is unavailable. “JUNNBRY” is believed to be currently owned by “Boehringer Ingelheim International GmbH”.